Industry Research Reports

Home > Reports > Pharma & Healthcare > Anti-Suicide Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Anti-Suicide Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 122 Pages

Report ld: 2334489

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant and anti-psychotic drugs are especially high in demand during economic crisis and social negligence. These drugs also serve as a therapy for preventing suicidal thoughts and attempts. However, overdose of these drugs can be fatal and therefore, needs to be administered under the direction of a physician.

The global market for Anti-Suicide Drugs was estimated to be worth US$ 4121 million in 2023 and is forecast to a readjusted size of US$ 5422 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030

Anti-Suicide Drugs Market Size

M= millions and B=billions

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-Suicide Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti-Suicide Drugs by region & country, by Type, and by Application.

The Anti-Suicide Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Suicide Drugs.

Market Segmentation

Report Metric
Details
Report Title
Anti-Suicide Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 5422 million
CAGR(2024-2030)
4%
Market Size Available for Years
2019-2030
Global Anti-Suicide Drugs Companies Covered
Pfizer, Inc, AstraZeneca Plc, Eli Lilly and Company, Allergan Plc, GlaxoSmithKline Plc, Merck & Co., Inc, H. Lundbeck A/S, NeuroRx, Inc, Johnson & Johnson, Janssen Pharmaceutical Ltd
Global Anti-Suicide Drugs Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti-Suicide Drugs Market, Segment by Type
Anti-Depressants and Anti-Anxiety Drugs

Anti-Psychotic Drugs

NMDA Antagonist

Antibiotic Analog
Global Anti-Suicide Drugs Market, Segment by Application
Hospitals

Retail Pharmacies

Online Pharmacies
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anti-Suicide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Anti-Suicide Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Anti-Suicide Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Anti-Suicide Drugs Product Introduction
    1.2 Global Anti-Suicide Drugs Market Size Forecast
        1.2.1 Global Anti-Suicide Drugs Sales Value (2019-2030)
        1.2.2 Global Anti-Suicide Drugs Sales Volume (2019-2030)
        1.2.3 Global Anti-Suicide Drugs Sales Price (2019-2030)
    1.3 Anti-Suicide Drugs Market Trends & Drivers
        1.3.1 Anti-Suicide Drugs Industry Trends
        1.3.2 Anti-Suicide Drugs Market Drivers & Opportunity
        1.3.3 Anti-Suicide Drugs Market Challenges
        1.3.4 Anti-Suicide Drugs Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Anti-Suicide Drugs Players Revenue Ranking (2023)
    2.2 Global Anti-Suicide Drugs Revenue by Company (2019-2024)
    2.3 Global Anti-Suicide Drugs Players Sales Volume Ranking (2023)
    2.4 Global Anti-Suicide Drugs Sales Volume by Company Players (2019-2024)
    2.5 Global Anti-Suicide Drugs Average Price by Company (2019-2024)
    2.6 Key Manufacturers Anti-Suicide Drugs Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Anti-Suicide Drugs Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Anti-Suicide Drugs
    2.9 Anti-Suicide Drugs Market Competitive Analysis
        2.9.1 Anti-Suicide Drugs Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Anti-Suicide Drugs Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Suicide Drugs as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Anti-Depressants and Anti-Anxiety Drugs
        3.1.2 Anti-Psychotic Drugs
        3.1.3 NMDA Antagonist
        3.1.4 Antibiotic Analog
    3.2 Global Anti-Suicide Drugs Sales Value by Type
        3.2.1 Global Anti-Suicide Drugs Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Anti-Suicide Drugs Sales Value, by Type (2019-2030)
        3.2.3 Global Anti-Suicide Drugs Sales Value, by Type (%) (2019-2030)
    3.3 Global Anti-Suicide Drugs Sales Volume by Type
        3.3.1 Global Anti-Suicide Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Anti-Suicide Drugs Sales Volume, by Type (2019-2030)
        3.3.3 Global Anti-Suicide Drugs Sales Volume, by Type (%) (2019-2030)
    3.4 Global Anti-Suicide Drugs Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Retail Pharmacies
        4.1.3 Online Pharmacies
    4.2 Global Anti-Suicide Drugs Sales Value by Application
        4.2.1 Global Anti-Suicide Drugs Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Anti-Suicide Drugs Sales Value, by Application (2019-2030)
        4.2.3 Global Anti-Suicide Drugs Sales Value, by Application (%) (2019-2030)
    4.3 Global Anti-Suicide Drugs Sales Volume by Application
        4.3.1 Global Anti-Suicide Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Anti-Suicide Drugs Sales Volume, by Application (2019-2030)
        4.3.3 Global Anti-Suicide Drugs Sales Volume, by Application (%) (2019-2030)
    4.4 Global Anti-Suicide Drugs Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Anti-Suicide Drugs Sales Value by Region
        5.1.1 Global Anti-Suicide Drugs Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Anti-Suicide Drugs Sales Value by Region (2019-2024)
        5.1.3 Global Anti-Suicide Drugs Sales Value by Region (2025-2030)
        5.1.4 Global Anti-Suicide Drugs Sales Value by Region (%), (2019-2030)
    5.2 Global Anti-Suicide Drugs Sales Volume by Region
        5.2.1 Global Anti-Suicide Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Anti-Suicide Drugs Sales Volume by Region (2019-2024)
        5.2.3 Global Anti-Suicide Drugs Sales Volume by Region (2025-2030)
        5.2.4 Global Anti-Suicide Drugs Sales Volume by Region (%), (2019-2030)
    5.3 Global Anti-Suicide Drugs Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Anti-Suicide Drugs Sales Value, 2019-2030
        5.4.2 North America Anti-Suicide Drugs Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Anti-Suicide Drugs Sales Value, 2019-2030
        5.5.2 Europe Anti-Suicide Drugs Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Anti-Suicide Drugs Sales Value, 2019-2030
        5.6.2 Asia Pacific Anti-Suicide Drugs Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Anti-Suicide Drugs Sales Value, 2019-2030
        5.7.2 South America Anti-Suicide Drugs Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Anti-Suicide Drugs Sales Value, 2019-2030
        5.8.2 Middle East & Africa Anti-Suicide Drugs Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Anti-Suicide Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Anti-Suicide Drugs Sales Value
        6.2.1 Key Countries/Regions Anti-Suicide Drugs Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Anti-Suicide Drugs Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Anti-Suicide Drugs Sales Value, 2019-2030
        6.3.2 United States Anti-Suicide Drugs Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Anti-Suicide Drugs Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Anti-Suicide Drugs Sales Value, 2019-2030
        6.4.2 Europe Anti-Suicide Drugs Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Anti-Suicide Drugs Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Anti-Suicide Drugs Sales Value, 2019-2030
        6.5.2 China Anti-Suicide Drugs Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Anti-Suicide Drugs Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Anti-Suicide Drugs Sales Value, 2019-2030
        6.6.2 Japan Anti-Suicide Drugs Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Anti-Suicide Drugs Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Anti-Suicide Drugs Sales Value, 2019-2030
        6.7.2 South Korea Anti-Suicide Drugs Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Anti-Suicide Drugs Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Anti-Suicide Drugs Sales Value, 2019-2030
        6.8.2 Southeast Asia Anti-Suicide Drugs Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Anti-Suicide Drugs Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Anti-Suicide Drugs Sales Value, 2019-2030
        6.9.2 India Anti-Suicide Drugs Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Anti-Suicide Drugs Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Pfizer, Inc
        7.1.1 Pfizer, Inc Company Information
        7.1.2 Pfizer, Inc Introduction and Business Overview
        7.1.3 Pfizer, Inc Anti-Suicide Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Pfizer, Inc Anti-Suicide Drugs Product Offerings
        7.1.5 Pfizer, Inc Recent Development
    7.2 AstraZeneca Plc
        7.2.1 AstraZeneca Plc Company Information
        7.2.2 AstraZeneca Plc Introduction and Business Overview
        7.2.3 AstraZeneca Plc Anti-Suicide Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 AstraZeneca Plc Anti-Suicide Drugs Product Offerings
        7.2.5 AstraZeneca Plc Recent Development
    7.3 Eli Lilly and Company
        7.3.1 Eli Lilly and Company Company Information
        7.3.2 Eli Lilly and Company Introduction and Business Overview
        7.3.3 Eli Lilly and Company Anti-Suicide Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Eli Lilly and Company Anti-Suicide Drugs Product Offerings
        7.3.5 Eli Lilly and Company Recent Development
    7.4 Allergan Plc
        7.4.1 Allergan Plc Company Information
        7.4.2 Allergan Plc Introduction and Business Overview
        7.4.3 Allergan Plc Anti-Suicide Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Allergan Plc Anti-Suicide Drugs Product Offerings
        7.4.5 Allergan Plc Recent Development
    7.5 GlaxoSmithKline Plc
        7.5.1 GlaxoSmithKline Plc Company Information
        7.5.2 GlaxoSmithKline Plc Introduction and Business Overview
        7.5.3 GlaxoSmithKline Plc Anti-Suicide Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 GlaxoSmithKline Plc Anti-Suicide Drugs Product Offerings
        7.5.5 GlaxoSmithKline Plc Recent Development
    7.6 Merck & Co., Inc
        7.6.1 Merck & Co., Inc Company Information
        7.6.2 Merck & Co., Inc Introduction and Business Overview
        7.6.3 Merck & Co., Inc Anti-Suicide Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Merck & Co., Inc Anti-Suicide Drugs Product Offerings
        7.6.5 Merck & Co., Inc Recent Development
    7.7 H. Lundbeck A/S
        7.7.1 H. Lundbeck A/S Company Information
        7.7.2 H. Lundbeck A/S Introduction and Business Overview
        7.7.3 H. Lundbeck A/S Anti-Suicide Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 H. Lundbeck A/S Anti-Suicide Drugs Product Offerings
        7.7.5 H. Lundbeck A/S Recent Development
    7.8 NeuroRx, Inc
        7.8.1 NeuroRx, Inc Company Information
        7.8.2 NeuroRx, Inc Introduction and Business Overview
        7.8.3 NeuroRx, Inc Anti-Suicide Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 NeuroRx, Inc Anti-Suicide Drugs Product Offerings
        7.8.5 NeuroRx, Inc Recent Development
    7.9 Johnson & Johnson
        7.9.1 Johnson & Johnson Company Information
        7.9.2 Johnson & Johnson Introduction and Business Overview
        7.9.3 Johnson & Johnson Anti-Suicide Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Johnson & Johnson Anti-Suicide Drugs Product Offerings
        7.9.5 Johnson & Johnson Recent Development
    7.10 Janssen Pharmaceutical Ltd
        7.10.1 Janssen Pharmaceutical Ltd Company Information
        7.10.2 Janssen Pharmaceutical Ltd Introduction and Business Overview
        7.10.3 Janssen Pharmaceutical Ltd Anti-Suicide Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Janssen Pharmaceutical Ltd Anti-Suicide Drugs Product Offerings
        7.10.5 Janssen Pharmaceutical Ltd Recent Development

 8 Industry Chain Analysis
    8.1 Anti-Suicide Drugs Industrial Chain
    8.2 Anti-Suicide Drugs Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Anti-Suicide Drugs Sales Model
        8.5.2 Sales Channel
        8.5.3 Anti-Suicide Drugs Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Anti-Suicide Drugs Market Trends
    Table 2. Anti-Suicide Drugs Market Drivers & Opportunity
    Table 3. Anti-Suicide Drugs Market Challenges
    Table 4. Anti-Suicide Drugs Market Restraints
    Table 5. Global Anti-Suicide Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Anti-Suicide Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Anti-Suicide Drugs Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Anti-Suicide Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Anti-Suicide Drugs Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Anti-Suicide Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Anti-Suicide Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Anti-Suicide Drugs
    Table 13. Global Anti-Suicide Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Suicide Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Anti-Suicide Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Anti-Suicide Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Anti-Suicide Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Anti-Suicide Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Anti-Suicide Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Anti-Suicide Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Anti-Suicide Drugs Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Anti-Suicide Drugs Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Anti-Suicide Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Anti-Suicide Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Anti-Suicide Drugs Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Anti-Suicide Drugs Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Anti-Suicide Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Anti-Suicide Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Anti-Suicide Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Anti-Suicide Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Anti-Suicide Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Anti-Suicide Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Anti-Suicide Drugs Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Anti-Suicide Drugs Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Anti-Suicide Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Anti-Suicide Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Anti-Suicide Drugs Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Anti-Suicide Drugs Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Anti-Suicide Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Anti-Suicide Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Anti-Suicide Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Anti-Suicide Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Anti-Suicide Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Anti-Suicide Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Anti-Suicide Drugs Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Anti-Suicide Drugs Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Anti-Suicide Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Anti-Suicide Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Anti-Suicide Drugs Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Anti-Suicide Drugs Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Anti-Suicide Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Anti-Suicide Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Anti-Suicide Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Anti-Suicide Drugs Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Anti-Suicide Drugs Sales Volume, (2025-2030) & (K Units)
    Table 57. Pfizer, Inc Company Information
    Table 58. Pfizer, Inc Introduction and Business Overview
    Table 59. Pfizer, Inc Anti-Suicide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Pfizer, Inc Anti-Suicide Drugs Product Offerings
    Table 61. Pfizer, Inc Recent Development
    Table 62. AstraZeneca Plc Company Information
    Table 63. AstraZeneca Plc Introduction and Business Overview
    Table 64. AstraZeneca Plc Anti-Suicide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. AstraZeneca Plc Anti-Suicide Drugs Product Offerings
    Table 66. AstraZeneca Plc Recent Development
    Table 67. Eli Lilly and Company Company Information
    Table 68. Eli Lilly and Company Introduction and Business Overview
    Table 69. Eli Lilly and Company Anti-Suicide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Eli Lilly and Company Anti-Suicide Drugs Product Offerings
    Table 71. Eli Lilly and Company Recent Development
    Table 72. Allergan Plc Company Information
    Table 73. Allergan Plc Introduction and Business Overview
    Table 74. Allergan Plc Anti-Suicide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Allergan Plc Anti-Suicide Drugs Product Offerings
    Table 76. Allergan Plc Recent Development
    Table 77. GlaxoSmithKline Plc Company Information
    Table 78. GlaxoSmithKline Plc Introduction and Business Overview
    Table 79. GlaxoSmithKline Plc Anti-Suicide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. GlaxoSmithKline Plc Anti-Suicide Drugs Product Offerings
    Table 81. GlaxoSmithKline Plc Recent Development
    Table 82. Merck & Co., Inc Company Information
    Table 83. Merck & Co., Inc Introduction and Business Overview
    Table 84. Merck & Co., Inc Anti-Suicide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Merck & Co., Inc Anti-Suicide Drugs Product Offerings
    Table 86. Merck & Co., Inc Recent Development
    Table 87. H. Lundbeck A/S Company Information
    Table 88. H. Lundbeck A/S Introduction and Business Overview
    Table 89. H. Lundbeck A/S Anti-Suicide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. H. Lundbeck A/S Anti-Suicide Drugs Product Offerings
    Table 91. H. Lundbeck A/S Recent Development
    Table 92. NeuroRx, Inc Company Information
    Table 93. NeuroRx, Inc Introduction and Business Overview
    Table 94. NeuroRx, Inc Anti-Suicide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. NeuroRx, Inc Anti-Suicide Drugs Product Offerings
    Table 96. NeuroRx, Inc Recent Development
    Table 97. Johnson & Johnson Company Information
    Table 98. Johnson & Johnson Introduction and Business Overview
    Table 99. Johnson & Johnson Anti-Suicide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Johnson & Johnson Anti-Suicide Drugs Product Offerings
    Table 101. Johnson & Johnson Recent Development
    Table 102. Janssen Pharmaceutical Ltd Company Information
    Table 103. Janssen Pharmaceutical Ltd Introduction and Business Overview
    Table 104. Janssen Pharmaceutical Ltd Anti-Suicide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Janssen Pharmaceutical Ltd Anti-Suicide Drugs Product Offerings
    Table 106. Janssen Pharmaceutical Ltd Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Anti-Suicide Drugs Downstream Customers
    Table 110. Anti-Suicide Drugs Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-Suicide Drugs Product Picture
    Figure 2. Global Anti-Suicide Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Anti-Suicide Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Anti-Suicide Drugs Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Anti-Suicide Drugs Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Anti-Suicide Drugs Report Years Considered
    Figure 7. Global Anti-Suicide Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Anti-Suicide Drugs Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Suicide Drugs Revenue in 2023
    Figure 10. Anti-Suicide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Anti-Depressants and Anti-Anxiety Drugs Picture
    Figure 12. Anti-Psychotic Drugs Picture
    Figure 13. NMDA Antagonist Picture
    Figure 14. Antibiotic Analog Picture
    Figure 15. Global Anti-Suicide Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Anti-Suicide Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Anti-Suicide Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Anti-Suicide Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Anti-Suicide Drugs Price by Type (2019-2030) & (USD/Unit)
    Figure 20. Product Picture of Hospitals
    Figure 21. Product Picture of Retail Pharmacies
    Figure 22. Product Picture of Online Pharmacies
    Figure 23. Global Anti-Suicide Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Anti-Suicide Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Anti-Suicide Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 26. Global Anti-Suicide Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Anti-Suicide Drugs Price by Application (2019-2030) & (USD/Unit)
    Figure 28. North America Anti-Suicide Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Anti-Suicide Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Anti-Suicide Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Anti-Suicide Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Anti-Suicide Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Anti-Suicide Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Anti-Suicide Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Anti-Suicide Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Anti-Suicide Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Anti-Suicide Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Anti-Suicide Drugs Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Anti-Suicide Drugs Sales Volume (%), (2019-2030)
    Figure 40. United States Anti-Suicide Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Anti-Suicide Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Anti-Suicide Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Anti-Suicide Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Anti-Suicide Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Anti-Suicide Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Anti-Suicide Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Anti-Suicide Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Anti-Suicide Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Anti-Suicide Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Anti-Suicide Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Anti-Suicide Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Anti-Suicide Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Anti-Suicide Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Anti-Suicide Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Anti-Suicide Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Anti-Suicide Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Anti-Suicide Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Anti-Suicide Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Anti-Suicide Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Anti-Suicide Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 61. Anti-Suicide Drugs Industrial Chain
    Figure 62. Anti-Suicide Drugs Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed

Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant and anti-psychotic drugs are especially high in demand during economic crisis and social negligence. These drugs also serve as a therapy for preventing suicidal thoughts and attempts. However, overdose of these drugs can be fatal and therefore, needs to be administered under the direction of a physician.

The global market for Anti-Suicide Drugs was estimated to be worth US$ 4121 million in 2023 and is forecast to a readjusted size of US$ 5422 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030

Market Segmentation

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 122 Pages

Report ld: 2334489

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3950.00

Multi Users License

USD 5925.00